Coolable Energy Emitter for Airway Nerve Ablation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current management techniques for pulmonary diseases such as asthma and COPD are neither completely successful nor free from side effects, and many patients do not comply with their drug prescription dosage regimen, leading to challenges in improving airflow resistance without patient compliance.

Innovation Solution

A treatment system that includes a delivery device configured to move along a lumen of an airway, forming lesions to attenuate nerve tissue signals while minimizing damage to non-targeted features, using a collapsible ablation assembly with a coolable energy emitter assembly to treat target sites without affecting non-targeted anatomical features.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If energy is delivered to ablate targeted tissue, then treatment effectiveness is improved, but non-targeted tissue damage increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidnon-targeted tissue damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The ablation assembly is designed to deliver energy locally to targeted tissue through a tissue-contacting portion while a cooling section simultaneously cools adjacent non-targeted tissue. This creates different thermal conditions in different spatial locations, allowing effective ablation of target tissue while protecting surrounding healthy tissue from thermal damage.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

A coolant is introduced as an intermediary substance between the energy emitter and non-targeted tissue. The coolant absorbs excess thermal energy and prevents it from reaching non-targeted tissue, thereby mediating the interaction between the ablation energy and surrounding structures to prevent collateral damage.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If drug treatment is used to manage pulmonary diseases, then patient compliance becomes a challenge, but treatment success is compromised

Engineering Contradiction:
Improvepatient complianceVSAvoidtreatment success
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The invention replaces the mechanical/administrative system of drug prescription and patient compliance with a direct energy-based therapeutic intervention. The ablation assembly delivers controlled energy to modify nerve tissue function, eliminating the need for ongoing patient adherence to medication regimens while achieving reliable therapeutic outcomes through a single procedural intervention.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The treatment system effectively reduces airway obstruction by relaxing airway smooth muscle and decreasing mucus production, thereby improving breathing ease and enhancing patient quality of life and health status.

Implementation Method 1

an energy emitter assembly configured to output energy to ablate targeted tissue of a bronchial tree and through which a coolant is capable of flowing so as to cool a tissue-contacting portion of the energy emitter assembly

Methodology Applied
Scientific EffectCooling: Cooling

Implementation Method 2

an energy emitter assembly configured to output energy to ablate targeted tissue

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 3

A delivery device includes an ablation assembly including a radiofrequency electrode configured to deliver radiofrequency energy to heat tissue of an airway wall

Methodology Applied
Scientific EffectJoule heating: Joule Heating

Data Source

PatentUS20250072957A1Delivery devices with coolable energy emitting assemblies
Publication Date: 2025.03.06 HOLAIRA INC
  • US20250072957A1 patent drawing
  • US20250072957A1 patent drawing
  • US20250072957A1 patent drawing

AI summary

Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input.